Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial-Reference-Cited by-同舟云学术

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East-Asian patients with type 2 diabetes in a multicentre, double-blind, randomized, parallel-arm, active comparator, phase III trial

Published:2018-06-05 Issue:9 Volume:20 Page:2121-2130
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Chen Yu Hong¹,Huang Chien-Ning²,Cho Young Min³,Li Pengfei⁴,Gu Liqun⁵,Wang Feng⁵,Yang Jun⁵^ORCID,Wang Wei Qing¹

Affiliation:

1. Ruijin Hospital; Shanghai Jiao Tong University; Shanghai China

2. Chung Shan Medical University Hospital; Taichung City Taiwan

3. Seoul National University College of Medicine; Seoul South Korea

4. Takeda Development Center Asia; Shanghai China

5. Lilly Suzhou Pharmaceutical Co. Ltd; Shanghai China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.13340/fullpdf

Reference42 articles.

1. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States;Ma;Ann N Y Acad Sci,2013

2. Prevalence and control of diabetes in Chinese adults;Xu;JAMA,2013

3. Type 2 diabetes;Chatterjee;Lancet,2017

4. Advances in the treatment of type 2 diabetes: impact of dulaglutide;Thompson;Diabetes Metab Syndr Obes,2016

5. Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review;Zhang;Sci Rep,2016

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials;Biomedicines;2024-08-23

2. Systematic review of the efficacy and safety of GLP-1 receptor agonists in the treatment of patients with type 2 diabetes mellitus;Pharmacia;2024-08-02

3. Efficacy and Safety of Oral Semaglutide in the Treatment of Type 2 Diabetes: A Meta‐Analysis;The Journal of Clinical Pharmacology;2024-06-14

4. A randomized, double‐blind trial assessing the efficacy and safety of two doses of dulaglutide in Japanese participants with type 2 diabetes (AWARD‐JPN);Diabetes, Obesity and Metabolism;2024-05-07

5. Comparing Efficacy and Safety of Glucagon-Like Peptide 1 (GLP-1) Agonist Versus Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitors in Chinese Patients with Type 2 Diabetes Mellitus: A Preliminary Study;International Journal of Pharmacology;2024-05-01